AAAAAA

   
Results: 1-22 |
Results: 22
TIMING OF COMBINED CHEMORADIOTHERAPY IN THE CONSERVATIVE TREATMENT OFLOCALLY ADVANCED BREAST-CANCER (LABC)
Authors: PIERGA JY CAMPANA F LAGUERRE B PALANGIE T FOURQUET A ASSELAIN B DIERAS V BEUZEBOC P DORVAL T SCHOLL S POUILLART P
Citation: Jy. Pierga et al., TIMING OF COMBINED CHEMORADIOTHERAPY IN THE CONSERVATIVE TREATMENT OFLOCALLY ADVANCED BREAST-CANCER (LABC), European journal of cancer, 34, 1998, pp. 42-42
INITIAL VERSUS DELAYED RADIOTHERAPY COMBINED WITH CONTINUOUS 5-FLUOROURACILE (F), CYCLOPHOSPHAMIDE (C) AND DOXORUBICINE (A) IN INFLAMMATORYBREAST-CANCER (IBC)
Authors: PALANGIE T ASSELAIN B CAMPANA F BEUZEBOC P DIERAS V DORVAL T JOUVE M PIERGA JY SCHOLL S POUILLART P
Citation: T. Palangie et al., INITIAL VERSUS DELAYED RADIOTHERAPY COMBINED WITH CONTINUOUS 5-FLUOROURACILE (F), CYCLOPHOSPHAMIDE (C) AND DOXORUBICINE (A) IN INFLAMMATORYBREAST-CANCER (IBC), European journal of cancer, 34, 1998, pp. 64-64
PREDICTIVE FACTORS OF RESPONSE TO FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC)
Authors: ROBAIN M PIERGA JY LAURENCE V JOUVE M DIERAS V BEUZEBOC P PALANGIE T DORVAL T SCHOLL S EXTRA JM ASSELAIN B POUILLART P
Citation: M. Robain et al., PREDICTIVE FACTORS OF RESPONSE TO FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 71-71
RANDOMIZED TRIAL COMPARING PROTRACTED INFUSION OF 5-FLUOROURACIL WITHWEEKLY DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH A MONTHLY BOLUS FAC REGIMEN IN METASTATIC BREAST-CARCINOMA (SPM90)
Authors: PIERGA JY JOUVE M ASSELAIN B LIVARTOWSKI A BEUZEBOC P DIERAS V SCHOLL S DORVAL T PALANGIE T GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., RANDOMIZED TRIAL COMPARING PROTRACTED INFUSION OF 5-FLUOROURACIL WITHWEEKLY DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH A MONTHLY BOLUS FAC REGIMEN IN METASTATIC BREAST-CARCINOMA (SPM90), British Journal of Cancer, 77(9), 1998, pp. 1474-1479
OVEREXPRESSION OF PDGF RECEPTOR-BETA IN DERMAL FIBROBLASTS OF LYMPHANGITIC POST RADIOTHERAPY RELAPSES OF BREAST-CARCINOMA
Authors: PIERGA JY BENYAHIA B CAMMILLERI S PALANGIE T BEUZEBOC P POUILLART P MAGDELENAT H
Citation: Jy. Pierga et al., OVEREXPRESSION OF PDGF RECEPTOR-BETA IN DERMAL FIBROBLASTS OF LYMPHANGITIC POST RADIOTHERAPY RELAPSES OF BREAST-CARCINOMA, Breast, 6(4), 1997, pp. 206-211
COST-QUALITY OF LIFE STUDY IN INFLAMMATORY BREAST-CANCER (IBC) OUT-PATIENTS RECEIVING HIGH-DOSE INTENSITY CHEMOTHERAPY WITH RH-GCSF AND STEM-CELL SUPPORT (PEGASE-2)
Authors: VIENS P BOUSCARY ML PALANGIE T ROCHE H FABBRO M JANVIER M DELOZIER T MACQUARTMOULIN G MOATTI JP
Citation: P. Viens et al., COST-QUALITY OF LIFE STUDY IN INFLAMMATORY BREAST-CANCER (IBC) OUT-PATIENTS RECEIVING HIGH-DOSE INTENSITY CHEMOTHERAPY WITH RH-GCSF AND STEM-CELL SUPPORT (PEGASE-2), European journal of cancer, 33, 1997, pp. 9-9
RESPONSE TO CHEMOTHERAPY IS THE FIRST PROGNOSTIC FACTOR IN METASTATICBREAST-CANCER
Authors: PIERGA JY JOUVE M ASSELAIN B DIERAS V BEUZEBOC P PALANGIE T DORVAL T GARCIAGIRALT E SCHOLL S POUILLART P
Citation: Jy. Pierga et al., RESPONSE TO CHEMOTHERAPY IS THE FIRST PROGNOSTIC FACTOR IN METASTATICBREAST-CANCER, European journal of cancer, 33, 1997, pp. 653-653
VALUE AND INDICATIONS OF SURGERY IN LOCALLY ADVANCED BREAST CANCERS
Authors: NOS C FOURQUET A COSSET JM ASSELAIN B PALANGIE T CLOUGH KB
Citation: C. Nos et al., VALUE AND INDICATIONS OF SURGERY IN LOCALLY ADVANCED BREAST CANCERS, European journal of cancer, 33, 1997, pp. 973-973
PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA
Authors: PIERGA JY DIERAS V BEUZEBOC P DORVAL T PALANGIE T JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA, Gynecologic oncology, 66(2), 1997, pp. 246-249
BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/
Authors: STOPPALYONNET D LAURENTPUIG P ESSIOUX L PAGES S ITHIER G LIGOT L FOURQUET A SALMON RJ CLOUGH KB POUILLART P ALAPETITE C ALEPEE B KLIJANIENKO J ASSELAIN B BEUZEBOC P BOURGEOIS D BOURGEOIS H BOURSTYN E BRUNIN F CAMPANA F CHAUVEINC F COSSET JM DECREMOUX P DELAROCHEFORDIERE A DELATTRE C DEMARGERIE V DESTGAUDENS AB DIERAS V DORVAL T DUBRAY B DURAND JC FALCOU MC FITOUSSI F GARCIAGIRALT E GIRAUD P GAUTIER C GUGLIELMINA JN HAMELIN JP HOFFMAN H JAULERRY C JOUVE M LABETA C LEGALL M MAGDELENAT H MEUNIER M MOSSERI V NGUYEN TT NATALI JC NEUENSCHWANDER S NOS C OLIVIER L PALANGIE T PIERGA JY PONTVERT D ROGE P SASTREGAREAU X SCHLIENGER P SCHOLL S SELINGER R THIBAULT F THIS P TROPHILME D VALIDIRE P VIELH P VILCOQ JR VINCENTSALOMON A VOILLEMOT N ZAFRANI B BONAITIPELLIE C THOMAS G
Citation: D. Stoppalyonnet et al., BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/, American journal of human genetics, 60(5), 1997, pp. 1021-1030
PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN, VINCRISTINE, AND ORAL CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
Authors: RAYMOND E PALANGIE T JOUVE M ASSELAIN B DIERAS V BEUZEBOC P DORVAL T GARCIAGIRALT E LIVARTOWSKI A SCHOLL S POUILLART P
Citation: E. Raymond et al., PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN, VINCRISTINE, AND ORAL CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER, Cancer investigation, 14(2), 1996, pp. 91-97
PHASE-II TRIAL OF DECAPEPTYL (D-TRP-6), A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG IN UNTREATED ADVANCED BREAST-CANCER
Authors: GARCIAGIRALT E BEUZEBOC P DIERAS V DORVAL T JOUVE M LIVARTOWSKI A PALANGIE T SCHOLL S POUILLART P
Citation: E. Garciagiralt et al., PHASE-II TRIAL OF DECAPEPTYL (D-TRP-6), A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG IN UNTREATED ADVANCED BREAST-CANCER, American journal of clinical oncology, 19(5), 1996, pp. 455-458
THE DOCTOR-PATIENT-RELATIONSHIP IN ONCOLO GIC SONOGRAPHY - THE RIGHT APPROACH
Authors: LECLERE J OLLIVIER L PACAULT V PALANGIE T
Citation: J. Leclere et al., THE DOCTOR-PATIENT-RELATIONSHIP IN ONCOLO GIC SONOGRAPHY - THE RIGHT APPROACH, Journal de radiologie, 77(6), 1996, pp. 405-409
TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY
Authors: PIERGA JY DIERAS V PARAISO D DORVAL T PALANGIE T BEUZEBOC P JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY, Gynecologic oncology, 60(1), 1996, pp. 59-63
MENINGEAL CARCINOMATOSIS IN PATIENTS WITH BREAST-CARCINOMA - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF A HIGH-DOSE INTRATHECAL METHOTREXATE REGIMEN
Authors: FIZAZI K ASSELAIN B VINCENTSALOMON A JOUVE M DIERAS V PALANGIE T BEUZEBOC P DORVAL T POUILLART P
Citation: K. Fizazi et al., MENINGEAL CARCINOMATOSIS IN PATIENTS WITH BREAST-CARCINOMA - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF A HIGH-DOSE INTRATHECAL METHOTREXATE REGIMEN, Cancer, 77(7), 1996, pp. 1315-1323
BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL
Authors: SCHOLL SM PIERGA JY ASSELAIN B BEUZEBOC P DORVAL T GARCIAGIRALT E JOUVE M PALANGIE T REMVIKOS Y DURAND JC FOURQUET A POUILLART P
Citation: Sm. Scholl et al., BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL, European journal of cancer, 31A(12), 1995, pp. 1969-1975
PROGNOSTIC FACTORS IN INFLAMMATORY BREAST-CANCER AND THERAPEUTIC IMPLICATIONS
Authors: PALANGIE T MOSSERI V MIHURA J CAMPANA F BEUZEBOC P DORVAL T GARCIAGIRALT E JOUVE M SCHOLL S ASSELAIN B POUILLART P
Citation: T. Palangie et al., PROGNOSTIC FACTORS IN INFLAMMATORY BREAST-CANCER AND THERAPEUTIC IMPLICATIONS, European journal of cancer, 30A(7), 1994, pp. 921-927
NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH TUMORS CONSIDERED TOO LARGE FOR BREAST-CONSERVING SURGERY - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL - S6
Authors: SCHOLL SM FOURQUET A ASSELAIN B PIERGA JY VILCOQ JR DURAND JC DORVAL T PALANGIE T JOUVE M BEUZEBOC P GARCIOGIRALT E SALMON RJ DELAROCHEFORDIERE A CAMPANA F POUILLART P
Citation: Sm. Scholl et al., NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH TUMORS CONSIDERED TOO LARGE FOR BREAST-CONSERVING SURGERY - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL - S6, European journal of cancer, 30A(5), 1994, pp. 645-652
LONG-TERM RESULTS OF A RANDOMIZED TRIAL COMPARING REGIMENS OF CYCLOPHOSPHAMIDE AND FLUOROURACIL WITH EITHER MITOXANTRONE OR DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: POUILLART P FOLLEZOU JY PALANGIE T FEUILHADE F GEORGE C RICHARDS E
Citation: P. Pouillart et al., LONG-TERM RESULTS OF A RANDOMIZED TRIAL COMPARING REGIMENS OF CYCLOPHOSPHAMIDE AND FLUOROURACIL WITH EITHER MITOXANTRONE OR DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 30A(5), 1994, pp. 715-716
CONCOMITANT RADIOCHEMOTHERAPY IN INFLAMMA TORY BREAST-CARCINOMA
Authors: CAMPANA F PALANGIE T POUILLART P FOURQUET A
Citation: F. Campana et al., CONCOMITANT RADIOCHEMOTHERAPY IN INFLAMMA TORY BREAST-CARCINOMA, Pathologie et biologie, 42(1), 1994, pp. 15-15
CIRCULATING LEVELS OF COLONY-STIMULATING FACTOR-1 AS A PROGNOSTIC INDICATOR IN 82 PATIENTS WITH EPITHELIAL OVARIAN-CANCER
Authors: SCHOLL SM BASCOU CH MOSSERI V OLIVARES R MAGDELENAT H DORVAL T PALANGIE T VALIDIRE P POUILLART P STANLEY ER
Citation: Sm. Scholl et al., CIRCULATING LEVELS OF COLONY-STIMULATING FACTOR-1 AS A PROGNOSTIC INDICATOR IN 82 PATIENTS WITH EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 69(2), 1994, pp. 342-346
MALIGNANT SQUAMOUS DEGENERATION OF OVARIAN DERMOID CYSTS - REPORT OF 2 CASES
Authors: BEUZEBOC P DORVAL T MATHIEU G GARCIAGIRALT E JOUVE M LIVARTOWSKI A PALANGIE T SCHOLL S POUILLART P
Citation: P. Beuzeboc et al., MALIGNANT SQUAMOUS DEGENERATION OF OVARIAN DERMOID CYSTS - REPORT OF 2 CASES, Annales de chirurgie, 47(7), 1993, pp. 641-644
Risultati: 1-22 |